Ignite Creation Date:
2024-05-06 @ 9:25 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02977468
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2016-11-28
Brief Title:
Effects of MK-3475 Pembrolizumab on the Breast Tumor Microenvironment in Triple Negative Breast Cancer
Sponsor:
Eileen Connolly
Organization:
Columbia University
Organization Data
Organization:
Columbia University
Class:
OTHER
Study ID:
AAAQ7863
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eileen Connolly
Lead Sponsor Class:
OTHER
Responsible Party:
Eileen Connolly
Responsible Party Title:
Assistant Professor of Radiation Oncology
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Columbia University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |